|
|||||
|
|
Real-World Assessment of Clinical Outcomes Among First-Line Sunitinib Patients with Clear Cell Metastatic Renal Cell Carcinoma (mRCC) by the International mRCC Database Consortium Risk Group |
|
| Authors: | Marie-France Savard J. Connor Wells Jeffrey Graham Shaan Dudani John A. Steinharter Bradley A. McGregor Frede Donskov Georg A. Bjarnason Ulka N. Vaishampayan Aaron R. Hansen Marco A.J. Iafolla Giovanni Zanotti Lynn Huynh Rose Chang Mei S. Duh Daniel Y.C. Heng |
| Affiliation: | 1. University of Calgary, Calgary, Canada;2. CancerCare Manitoba, University of Manitoba, Winnipeg, Canada;3. Dana-Farber Cancer Institute, Boston, Massachusetts, USA;4. Aarhus University Hospital, Aarhus, Denmark;5. Sunnybrook Health Sciences Centre, Toronto, Canada;6. Karmanos Cancer Institute, Detroit, Michigan, USA;7. Princess Margaret Cancer Centre, Toronto, Canada;8. Pfizer, Inc., New York, New York, USA;9. Analysis Group, Inc., Boston, Massachusetts, USA |
| Abstract: | |
| Keywords: | International Metastatic Renal Cell Carcinoma Database Consortium Metastatic renal cell carcinoma Sunitinib Real-world clinical outcome Overall survival |